TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Est. Return
18.15%
1 Year Est. Return
+18.15%
AUM
$2.63B
AUM Growth
-$21.2M
(-0.8%)
Holding
190
Top Buys
| 1 | +$45.7M | |
| 2 | +$22.8M | |
| 3 | +$19.9M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$18.2M |
| 5 |
Exelixis
EXEL
|
+$14.1M |
Top Sells
| 1 | +$47.2M | |
| 2 | +$26.4M | |
| 3 | +$24.7M | |
| 4 |
Lantheus
LNTH
|
+$21.7M |
| 5 |
Humana
HUM
|
+$19.9M |
Sector Composition
| 1 | Healthcare | 96.54% |
| 2 | Real Estate | 2.01% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$61.1B
| $28.7M | 1.09% |
143,214
|
|
||
27
Boston Scientific
BSX
$148B
| $28.3M | 1.08% |
565,990
-191,025
|
|
||
28
Medtronic
MDT
$131B
| $27.8M | 1.06% |
344,517
+18,345
|
|
||
29
Danaher
DHR
$161B
| $26.6M | 1.01% |
119,218
|
|
||
30
DexCom
DXCM
$25.3B
| $26.6M | 1.01% |
228,747
+10,732
|
|
||
31
Charles River Laboratories
CRL
$8.7B
| $23.8M | 0.91% |
118,083
+45,408
|
|
||
32
McKesson
MCK
$102B
| $23.7M | 0.9% |
66,455
|
|
||
33
HCA Healthcare
HCA
$114B
| $23.4M | 0.89% |
88,703
-16,300
|
|
||
34
Zoetis
ZTS
$55B
| $22.8M | 0.87% |
136,914
|
|
||
35
Jazz Pharmaceuticals
JAZZ
$10.2B
| $21.6M | 0.82% |
147,779
-35,003
|
|
||
36
Stryker
SYK
$140B
| $20.4M | 0.78% |
71,578
-92,550
|
|
||
|
37
Humana
HUM
$29B
| $17.9M | 0.68% |
36,794
-40,919
|
|
||
38
Novo Nordisk
NVO
$212B
| $17.7M | 0.67% |
222,646
-38,400
|
|
||
39
Molina Healthcare
MOH
$7.45B
| $16.5M | 0.63% |
61,856
-11,759
|
|
||
40
ResMed
RMD
$36.8B
| $16M | 0.61% |
73,189
+12,490
|
|
||
41
Edwards Lifesciences
EW
$49B
| $14.2M | 0.54% |
171,146
-242
|
|
||
|
42
Exelixis
EXEL
$11.7B
| $14.1M | 0.54% |
+726,639
|
|
||
43
United Therapeutics
UTHR
$20.4B
| $13.7M | 0.52% |
61,200
-53,877
|
|
||
44
Acadia Healthcare
ACHC
$1.49B
| $13.5M | 0.51% |
186,487
+45,298
|
|
||
45
Ascendis Pharma
ASND
$12.3B
| $13.3M | 0.51% |
123,791
|
|
||
46
uniQure
QURE
$1.58B
| $13.1M | 0.5% |
652,446
|
|
||
|
DOC
47
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $13M | 0.5% |
873,655
+704,914
|
|
||
48
BioNTech
BNTX
$23.2B
| $12.9M | 0.49% |
103,858
|
|
||
49
IQVIA
IQV
$38.8B
| $12.6M | 0.48% |
63,117
|
|
||
50
Novartis
NVS
$254B
| $12.5M | 0.48% |
136,225
|
|